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The monoclonal antibody OKT6 and antisera against 
S-100 protein have both been advocated as immunologic 
markers of Langerhans cells in the skin. S-100 anti-
serum has an advantage in its ability to stain Langer-
hans cells in paraffin tissues. In order to evaluate 
whether these antibodies stain equivalent numbers of 
Langer hans cells in skin, we compared the staining pat-
terns of S-100 antiserum and OKT6 antibody on biopsy 
specimens from 40 patients with leprosy using immu-
noperoxidase techniques. Utilizing OKT6 antibody, 
greater numbers of positive Langerhans cells were 
found in the epidermis in tuberculoid leprosy, reversal 
reaction, and erythema nodosum leprosum than in lep-
romatous leprosy. However, these differences were not 
observed with the S -100 antiserum and, overall, fewer 
cells were found as compared with the OKT6 antibody. 
In the dermis both antibodies stained "dendritic cells" 
that were found encircling granulomas in tuberculoid 
leprosy and reversal reaction. Staining in lepromatous 
leprosy granulomas, in contrast to the epidermal stain-
ing pattern, revealed rare OKT6-positive cells, whileS-
100 cells were numerous and were more diffusely dis-
tributed throughout the granuloma. Our results indicate 
that antiserum to S -100 protein and OKT6 antibody 
stain morphologically similar cells (dendritic cells), but 
do not provide comparable results concerning distribu-
tion and frequency of these cells. 
The avai labili ty of monoclonal antibody, OKT6, that reacts 
with Langerhans cells [1 -3] has provided a new tool for the 
investigation of Langerhans cell s in the ep idermis of a variety 
of dermatoses [ 4- 7]. This antibody recognizes a 49,000 dalton 
cell surface glycoprotein [8] . The use of this antibody is limited 
to frozen sections so that tissues routinely processed in paraffin 
cannot be used. An antibody that reacts with Langerhans cells 
in paraffin sections wou ld facilitate investigation of the fre-
quency and distribution of these cells in a variety of skin 
diseases. 
S-100 protein is an acid ca lcium binding protein present in 
the cytoplasm of a variety of cells including Langerhans cells 
[9,10]. Unl ike OKT6 antibody, S-100 antiserum can be used 
for routine immunostaining of paraffin sections. However, it is 
not known whether the two antisera produce equivalent results 
on human skin . Therefore, we undertook to compare the im-
munostaining patterns of OKT6 antibody and S-100 antiserum 
on human skin biopsy specimens. Because we have found 
distinct differences in the number of epidermal Langerhans 
cells throughout the spectrum of leprosy [ 4,5], and because we 
Manusc ript received ,June 20, 1983; accepted for publication April 
25, 1984. 
Supported in part by a grant from The Dermatology Foundation, 
the Heiser Program for Research in Leprosy, and The Military and 
Hospital ler Order of St. Lazarus of Jerusalem. 
Reprint requests to: Thomas H. Rea, M.D., Department of Derma-
tology, Room 8441, LAC/USC Medical Center, 1200 N. State Street, 
Los Angeles, Cali fornia 90033. 
Abbreviations: 
PBS: phosphate-buffered saline 
have "banked" 40 frozen blocks of leprosy skin lesions with 
corresponding paraffin blocks from the same biopsy specimen 
we elected to perform our study on these tissues. ' 
Both OKT6 and S-100 antisera may react also with Langer-
hans cells in the human dermis [10,11]. Therefore, we a lso 
undertook to compare these antisera in their ability to stain 
cells in the dermis of leprosy lesions. Our results show that the 
numbers of cells identified by these antisera in human epider-
mis and dermis are not equivalent. 
MATERIALS AND METHODS 
Skin biopsy specimens obtained from 40 patients with leprosy were 
bisected. Half the specimens were tixed in formaldehyde for routine 
paraffin embedding; half were coated in OCT, snap-frozen in liquid 
nitrogen, and then stored at -70"C. Classification (Table I) was ac-
cording to the criteria of Ridley [1 2]. with the reactional states identi-
fied as previously described [13] . 
OKT6 antibody was utilized in an indirect immunoperoxidase tech-
nique [5]. Cryostat sections were cut to 6 11m and fixed for 10 min in 
acetone. After 5 min in phosphate-buffered saline (PBS), mouse mon -
oclonal OKT6 (Ortho) antibody protein level/ml at 1:50 was applied 
for 15 min, followed by peroxidase-conjugated goat antimouse lgG 
(Tago) at 1:10 for 15 min, with a 5-min PBS wash between incubations. 
A colored reaction product was obtained using aminoethyl carbazole 
and hydrogen peroxide as substrate. Slides were counterstained with 
hematoxylin and mounted in glycerol jelly. Controls consisted of the 
use of an antibody of irrelevant specificity at the same concentration 
and of omission of the primary antibody in the indirect peroxidase 
method. 
Antiserum was prepared as follows. For comparison to the commer-
cial Dako antiserum, an S-100 protein fraction was isolated from fresh 
calf brain homogenate by ammonium sulfate precipitation and column 
chromatography with diethylaminoethyl cellulose-sephacel and Bio-
Gel P-60 [14]. The resulting S-100 fraction was assayed for amino acid 
composition, molecular weight, electrophoretic mobility, and reacted 
with a defined anti-S-100 antiserum (courtesy of Dr. S. E. Pfeiffer 
University of Connecticut) by double diffusion and immunoelectro: 
phoretic methods. All findings were consistent with published value 
for the aforementioned features [15]. A heteroantiserum was produced 
in rabbits by hyperimmunization with Freund's complete and incom-
plete adjuvants. 
For identification of the S-100 antigen, checkerboard titrations were 
employed to determine the optimal antibody concentrations in the 
peroxidase-antiperoxidase technique [10] . The serum was stored at 
-20"C until utilized at dilutions of 1:10 to 1:200. Initial antibody protein 
levels in the undiluted serum were 8 ng protein/mi. Paraffin sections 
were deparaffinized in xylene and rehydrated in graded ethanol con-
centrations, then treated for 20 min in 0.5% hydrogen peroxidase in 
methanol to block endogenous peroxidase activity. After washing in 
PBS the following reagents were sequentially applied, with 5-m.in 
washes with PBS between incubations: normal swine serum (Dako) 
1:20 for 10 min; anti-S-100 protein antibody (Dako) at 1:50 for 30 min; 
swine antirabbit immunoglobulin serum (Dako) at 1:20 for 30 min; 
rabbit peroxidase-antiperoxidase complex (Dako) at 1:30 for 30 min. 
Visualization of peroxidase activity was obtained with aminoethyl 
carbazole and hydrogen peroxide, and slides were counterstained in 
hematoxylin . Trypsinization of paraffin sections was not routinely 
performed, because staining of sections with or without trypsinization 
[16] yielded identical results. Identification of S-100 in representative 
acetone-fixed frozen sections produced equivalent results to paraffin 
sections, although frozen sections showed a "weaker" staining reaction. 
Because the goal of this study was to evaluate S-100 stain ing on paraffin 
sections, staining on frozen sections was not routinely performed. 
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TABLE I. Numbers of specimens graded by density of Langerhans cells 
in epidermis according to percentage of cells exhibiting cell-cell contact 
OKT6 S-100 
Patient classification 
< 10% > 10% < 10% >10% 
Tuberculoid 1 7 8 0 
Borderline 2 6 8 0 
Lepromatous 7 0 7 0 
Erythema nodosum leprosum 4 4 8 0 
Reversal reaction 3 4 7 0 
Lucios reaction 1 1 2 0 
Numbers were graded acco rding to density as to whether less than 
10% of the positive cells showed visible cell -cell contact of dendritic 
extensions with other positive cells, or whether greater than 10% of 
cell s exhibited positive cell- cell contact (i.e., a dense interconnecting 
meshwork). 
Controls 
The specificity of the staining for S-100 was assessed as follows: 
Tissue cont rols : Normal brain, gut (for myenteric plexi) and normal 
skin (for Langer hans cells, melanocytes, and peripheral nerve Schwann 
cells) embedded in paraffin and treated as for test sections served as 
positive controls. Peripheral Schwann cells in the experimental section 
also served as reliable indications for the successful staining of S-100 
protein. 
Reagent controls: (a) Specific immune blocking: Control consisted of 
exposure of test and control sections to unlabeled anti-S-100 antiserum 
followed by exposure to directly labeled anti-S-100 horseradish perox-
idase_ A significant total dim inution of staining was necessary and was 
noted not only in Langerhans cells but also in Schwann cells. 
dermis from lepromatous patients with or without erythema 
nodosum leprosum. 
S-100-positive cells in the dermis were a lso of dendritic 
morphology and were usually more numerous than OKT6-
positive cells, in contrast with epidermis. S-100-positive cells 
were frequent in tuberculoid and borderline specimens with or 
without reversal reaction and in lepromatous specimens. They 
were, however, absent (or very rare) in specimens from patients 
with erythema nodosum leprosum (Table II). In tuberculoid 
specimens S-100-positive cells often encircled granulomas (Fig 
(b) Antibody: Control consisted of antigen preabsorption. Anti-S- A 
100 antiserum was incubated overnight at 4 ·c with 1 mg/ ml S-100 
protein. Staining was performed with the resultant filtered centrifuged 
supernatant. Failure of the staining of Schwann cells and Langerhans 
cells was necessa ry and was noted. 
(c) Sections were incubated in preimmune rabbit serum at equivalent 
dilution instead of the anti-S-100 antibody. 
(d) Sections were incubated for endogenous peroxidase activity (mi-
nus blocking). 
(e) Sections were exposed to free horseradish peroxidase fo llowed by 
demonstration of perox idase activity as above. 
Langerhans cells were identified in the epidermis of immunostained 
preparations by their oval ce ll bodies and dendritic extensions. OKT6-
positive and S-100-positive cells in the dermis. oval with dendritic 
extensions, were evaluated for numbers and microanatomic location. 
RESULTS 
Epidermis 
OKT6-positive cells (presumptive Langerhans cells) were 
identified in the epidermis of tuberculoid and borderline spec-
imens in greater numbers t han in lepromatous specimens. Also, 
OKT -6 positive ce lls were identified in great numbers in the 
epidermis of the reactiona l states of reversal reaction and 
erythema nodosum leprosum. 
By contrast, anti-S-100 antibody demonstrated few positive 
cells in all specimens; S-100-positive Langerhans cells were 
well spaced with rare interconnections of dendrites (Table I, 
Fig 1). Dilutions of both antisera did not significantly reduce 
the numbers of positive cells in a selective fashion ; weakening 
of t he staining reaction was a constant feature of a ll Langer hans 
cells at levels of dilution in excess of 1:200 for S-100 antiserum, 
and 1:50 for OKT6 activity. At further di lution of S-100 anti-
serum, significant staining of Schwann cells was still visible, 
whi le Langer hans ce ll staining faded, reflecting the quantitative 
differences in amounts of S-100 protein in the two cell types. 
Dermis 
Considered as a whole, the tuberculoid and borderline spec-
imens, including those cases with reversal reaction , had large 
numbers of OKT6-pos itive ce lls in the dermis; the positive cells 
morphologically exhibited dendritic extensions and often en-
circled the granulomas. Simi lar posit ive cells were rare in the 
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FIG 1. Epidermis of tuberculoid leprosy. A, OKT6 immunostaining 
reveals numerous ovoi? cell bodies with dendrites exhibiting many 
mterconnect10ns resultmg 111 a meshlike network. B S-100 immune-
staining on specimen from same patient as (A) reveais few cell bodies 
and less than 10% of dendritic extensions exhibiting interconnections. 
(lmmunoperoxidase, hematoxylin, x 180.) 
TABLE II. Number of specimens with positive cells in the dermis of 
lepromatou.~ tissues 
Lepromatous with-
out erythema no-
dosum leprosum 
Lepromatous with 
erythema nodo-
sum leprosum 
OKT6 
< 5 cells/ > 5 cells/ 
tissue tissue 
7 0 
8 0 
S-100 
<5 cells/ > 5 cells/ 
tissue tissue 
6 
7 1 
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FI G 2. Dermis of tuberculoid leprosy. S-100 immunostaining dem-
onstrates positive dendritic ce lls surrounding a granuloma. (lmmuno-
peroxidase, hematoxylin , X 180.) 
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F IG 3. De rmi s of lepromatous leprosy. S-100 immunostainin g re-
veals scatte red pos it ive dendri t ic cells throughout gra nuloma. The cor-
responding OKT6 ·ta in was negative in t he dermis. (lmmunoperoxi -
dase, hematoxylin , x 180.) 
2), while in lepromatous specimens they we re distributed 
throughout the gra nuloma (F'i g 3). 
DISCUSSIO N 
Our resul ts indicate t hat OKT6 ant ibody and S- 100 anti -
se rum do not have identica l staining patterns in cuta neous 
specimens from leprosy patients. The OKT6 antibody is supe-
ri or to the S-100 ant ibody for ident ifi cation of Langerhans cells 
in the epidermis in terms of number of pos itive cell s ident ified. 
Further, OKT6 antibody gives different sta ining patterns of 
epidermal cells in different disease fi tates; specimens from 
patients with immunologically active tuberculoid leprosy, re-
versal reacti on, a nd erythema nodosum leprosum contained 
greate r numbers of OKT6- po. it ive Langerha ns cells in t he 
epidermis, as compared to lepromatous leprosy. By cont rast, 
anti-S-100 fa iled to reveal any differences in the number of 
pos it ive ce lls in t he epidermis. 
Of un ex pected in terest was the dermal sta ining pattern of S-
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100. S- 100 posit ive ce ll s were generally more numerous in t h e 
dermis as compared with OKT6-posit ive cells. In tuberculo id 
and borderline spec imens with or wi t hout reversal reactio n 
these ce ll s surrounded granulomas in a manner simila r to 
OKT6-posit ive cells. They were present throughout leprom a -
tous granulomas but absent from t hose wi t h erythema nodosum 
leprosum . 
It has been claimed that S-100 a ntibody sta ins Lange rha n s 
cells in the dermis [9] ; while the dendri t ic appearance and 
immunoelectron microscopic examination of OKT6-positive 
cells in the dermis suggest t hat they may also be Langerha ns 
cells [ 11], or at least close relatives. The fun ctiona l role of t hese 
cells is speculat ive, although they appear to correlate in num -
bers and locations wit h aspects of the host immune response. 
That S-100 stained fewer epidermal cells but greater numbe rs 
of dermal cells as compared wit h OKT6 suggests t hat t hese 
antibodies do not stain iden t ical populations of cells. This 
findin g, combined wi t h the obse rvation t hat increased concen -
tration of S- 100 ant ise ra does not increase t he numbers of 
posit ive epidermal cells, implies t hat t he hete rologous S-100 
antisera is not "weaker" t han the monoclonal OKT6 antibody. 
Instead, t he different populations of cells ident ified by t hese 
ant ise ra may be related to functional characteristics perhaps of 
Lange rhans ce lls. 
We conclude t hat alt hough both ant iserum to S-100 a nd 
OKT6 "ident ify" cells t hat are morphologically consistent with 
Lange rhans cells in t he epidermis, they do not recognize such 
cells in equi valent numbers. Similarly, t hese two ant ibod ies 
give disc repant results in relation to "dendri t ic cells" in t he 
dermis. Use of S-100 antise ra on pa ra ff"in sections cannot 
substitute for, but may provide addi t ional information to, 
OKT6 sta ining on frozen sections. Further investigation is 
required to dete rmine whether t hese patterns represent differ-
ent phenotypic subsets of a single cell populat ion a nd whether 
such differences have any biologic significance or diagnostic 
and prognostic va lue. 
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